Swiss All Share Index
15.902,97
PKT
+54,83
PKT
+0,35
%
Werbung
Analysen zu Swiss All Share Index-Werten
Datum | Rating | Analyst | |
---|---|---|---|
08.11.06 | Adecco SA buy | Bank Sarasin & Cie | |
06.11.06 | Lonza | Wirtschaftswoche | |
03.11.06 | UBS overweight | JP Morgan | |
03.11.06 | Zurich Insurance | DZ-Bank | |
06.11.06 | BB Biotech kaufen | Hamburger Sparkasse | |
14.11.06 | Nestlé kaufen | Weberbank | |
06.11.06 | UBS halten | National-Bank AG | |
03.11.06 | UBS halten | Helaba Trust | |
14.11.06 | Novartis kaufen | Weberbank | |
02.11.06 | ABB (Asea Brown Boveri) | Zürcher Kantonalbank | |
02.11.06 | UBS buy | Société Générale (SG) | |
31.10.06 | UBS halten | Helaba Trust | |
01.11.06 | Zurich Insurance overweight | JP Morgan | |
31.10.06 | UBS hold | SEB | |
30.10.06 | ABB (Asea Brown Boveri) kaufen | Euro am Sonntag | |
30.10.06 | Novartis kaufen | Die Actien-Börse | |
30.10.06 | Swiss Life buy | SRC Research | |
27.10.06 | Zurich Insurance | DZ-Bank | |
27.10.06 | UBS | DZ-Bank | |
27.10.06 | ABB (Asea Brown Boveri) kaufen | National-Bank AG | |
26.10.06 | ABB (Asea Brown Boveri) verkaufen | Helaba Trust | |
27.10.06 | ABB (Asea Brown Boveri) hold | Société Générale (SG) | |
27.10.06 | Sonova neutral | Bank Sarasin & Cie | |
26.10.06 | Adecco SA buy | Bank Sarasin & Cie | |
23.10.06 | Nestlé hold | Société Générale (SG) | |
23.10.06 | Novartis neutral | JP Morgan | |
20.10.06 | Novartis kaufen | Helaba Trust | |
20.10.06 | Nestlé kaufen | Hamburger Sparkasse | |
20.10.06 | Nestlé overweight | JP Morgan | |
20.10.06 | Zurich Insurance | DZ-Bank | |
20.10.06 | UBS | DZ-Bank | |
20.10.06 | Logitech Buy | Kaufman Bros., LP | |
20.10.06 | Novartis Overweight | Prudential Securities | |
20.10.06 | Nestlé buy | UBS | |
24.10.06 | Novartis buy | Jyske Bank | |
20.10.06 | Novartis halten | National-Bank AG | |
19.10.06 | Novartis buy | Merrill Lynch | |
19.10.06 | Nestlé outperform | Sanford C. Bernstein & Co | |
19.10.06 | Novartis akkumulieren | Independent Research | |
19.10.06 | Nestlé akkumulieren | Independent Research |